https://www.contentrheum.com/ 2025-01-15T06:42:28+00:00 1.00 https://www.contentrheum.com/faculty-listing 2025-01-15T06:42:28+00:00 0.80 https://www.contentrheum.com/podcasts-listing 2025-01-15T06:42:28+00:00 0.80 https://www.contentrheum.com/disease 2025-01-15T06:42:28+00:00 0.80 https://www.contentrheum.com/faculty/candace-ryan 2025-01-15T06:42:28+00:00 0.80 https://www.contentrheum.com/faculty/jeannette-hart 2025-01-15T06:42:28+00:00 0.80 https://www.contentrheum.com/faculty/stacey-johnson 2025-01-15T06:42:28+00:00 0.80 https://www.contentrheum.com/faculty/cassie-dolecki 2025-01-15T06:42:28+00:00 0.80 https://www.contentrheum.com/faculty/william-saalfeld 2025-01-15T06:42:28+00:00 0.80 https://www.contentrheum.com/faculty/wendy-simmons 2025-01-15T06:42:28+00:00 0.80 https://www.contentrheum.com/faculty/claudia-rivera-salas 2025-01-15T06:42:28+00:00 0.80 https://www.contentrheum.com/faculty/ingrid-pan 2025-01-15T06:42:28+00:00 0.80 https://www.contentrheum.com/faculty/christy-vath 2025-01-15T06:42:28+00:00 0.80 https://www.contentrheum.com/faculty/jessica-farrell 2025-01-15T06:42:28+00:00 0.80 https://www.contentrheum.com/faculty/heather-mambretti 2025-01-15T06:42:28+00:00 0.80 https://www.contentrheum.com/faculty/robert-laugherty 2025-01-15T06:42:28+00:00 0.80 https://www.contentrheum.com/faculty/kyle-george 2025-01-15T06:42:28+00:00 0.80 https://www.contentrheum.com/faculty/amanda-mixon 2025-01-15T06:42:28+00:00 0.80 https://www.contentrheum.com/faculty/amber-hudgins 2025-01-15T06:42:28+00:00 0.80 https://www.contentrheum.com/faculty/danielle-gatti-palumbo 2025-01-15T06:42:28+00:00 0.80 https://www.contentrheum.com/faculty/katie-springer 2025-01-15T06:42:28+00:00 0.80 https://www.contentrheum.com/faculty-listing?keyword= 2025-01-15T06:42:28+00:00 0.80 https://www.contentrheum.com/podcasts-detail-page/rhappcast-navigating-the-complexities-il-17-inhibitors-and-ibd-risk 2025-01-15T06:42:28+00:00 0.80 https://www.contentrheum.com/podcasts-detail-page/lost-time-the-impact-of-delaying-optimal-therapy-in-ra-spa-patients-without-disease-control 2025-01-15T06:42:28+00:00 0.80 https://www.contentrheum.com/podcasts-detail-page/navigating-remission-in-rheumatoid-arthritis-approaches-advances-impact-and-insights 2025-01-15T06:42:28+00:00 0.80 https://www.contentrheum.com/podcasts-detail-page/cd64-binding-description-relevance-and-potential-clinical-implications 2025-01-15T06:42:28+00:00 0.80 https://www.contentrheum.com/podcasts-detail-page/biosimilars-and-the-patient-perspective 2025-01-15T06:42:28+00:00 0.80 https://www.contentrheum.com/podcasts-detail-page/rhappcast-biosimilars-unveiled-empowering-apps-for-better-patient-conversations 2025-01-15T06:42:28+00:00 0.80 https://www.contentrheum.com/podcasts-detail-page/rhappcast-the-il23il17-cascade-and-implications-in-the-pathogenesis-of-psa-pso-and-ibd 2025-01-15T06:42:28+00:00 0.80 https://www.contentrheum.com/faq-video-detail-page/how-do-you-interpret-radiographic-progression-using-modified-vdhs-or-mtss 2025-01-15T06:42:28+00:00 0.80 https://www.contentrheum.com/medical-review-video-detail-page/what-is-the-safety-profile-of-guselkumab-in-pso-and-psa 2025-01-15T06:42:28+00:00 0.80 https://www.contentrheum.com/faq-video-detail-page/how-does-axial-psa-differ-from-as-clinically-genetically-and-radiographically 2025-01-15T06:42:28+00:00 0.80 https://www.contentrheum.com/journal-club-video-detail-page/six-month-persistence-and-multi-domain-effectiveness-of-guselkumab-in-adults-with-psoriatic-arthritis-real-world-data-from-the-corevitas-psoriatic-arthritisspondyloarthritis-registry 2025-01-15T06:42:28+00:00 0.80 https://www.contentrheum.com/faq-video-detail-page/why-is-binding-cd64-important-when-discussing-il23-directed-therapy 2025-01-15T06:42:28+00:00 0.80 https://www.contentrheum.com/medical-review-video-detail-page/how-is-guselkumab-dosed-in-pso-psa-and-ibd 2025-01-15T06:42:28+00:00 0.80 https://www.contentrheum.com/faq-video-detail-page/provide-immunologic-rationale-for-il23-directed-therapy-in-psa-pso-and-ibd 2025-01-15T06:42:28+00:00 0.80 https://www.contentrheum.com/faq-video-detail-page/what-is-the-role-of-il23il17-axis-in-rheumatic-disease 2025-01-15T06:42:28+00:00 0.80 https://www.contentrheum.com/faq-video-detail-page/describe-the-il23il17-axis 2025-01-15T06:42:28+00:00 0.80 https://www.contentrheum.com/medical-review-video-detail-page/describe-the-mechanism-of-action-of-guselkumab 2025-01-15T06:42:28+00:00 0.80 https://www.contentrheum.com/faq-video-detail-page/define-compare-and-contrast-humoral-and-cell-mediated-immunity 2025-01-15T06:42:28+00:00 0.80 https://www.contentrheum.com/medical-review-video-detail-page/what-is-non-responder-imputation-and-how-is-it-utilized-in-clinical-trials 2025-01-15T06:42:28+00:00 0.80 https://www.contentrheum.com/journal-club-video-detail-page/data-review-from-the-phase-iii-discover-2-trials 2025-01-15T06:42:28+00:00 0.80 https://www.contentrheum.com/journal-club-video-detail-page/differentiation-of-therapeutic-antibodies-targeting-interleukin-il-23 2025-01-15T06:42:28+00:00 0.80 https://www.contentrheum.com/disease-detail/il-23 2025-01-15T06:42:28+00:00 0.80 https://www.contentrheum.com/medical-review-video-detail-page/what-is-the-efficacy-of-ixekizumab-across-the-grappa-eular-domains 2025-01-15T06:42:28+00:00 0.80 https://www.contentrheum.com/medical-review-video-detail-page/what-is-the-safety-profile-of-ixekizumab-in-psa-and-axspa 2025-01-15T06:42:28+00:00 0.80 https://www.contentrheum.com/faq-video-detail-page/provide-immunologic-rationale-for-il17-directed-therapy-in-psa-as-and-nr-axspa 2025-01-15T06:42:28+00:00 0.80 https://www.contentrheum.com/medical-review-video-detail-page/describe-the-mechanism-of-action-of-ixekizumab 2025-01-15T06:42:28+00:00 0.80 https://www.contentrheum.com/faq-video-detail-page/describe-the-il17-induced-inflammatory-cascade 2025-01-15T06:42:28+00:00 0.80 https://www.contentrheum.com/disease-detail/il-17 2025-01-15T06:42:28+00:00 0.80 https://www.contentrheum.com/journal-club-video-detail-page/safety-and-efficacy-of-upadacitinib-for-pediatric-patients-with-polyarticular-course-juvenile-idiopathic-arthritis-an-interim-analysis-of-an-open-label-phase-1-trial 2025-01-15T06:42:28+00:00 0.80 https://www.contentrheum.com/journal-club-video-detail-page/long-term-efficacy-and-safety-following-switch-between-upadacitinib-and-adalimumab-in-patients-with-rheumatoid-arthritis-5-year-data-from-select-compare 2025-01-15T06:42:28+00:00 0.80 https://www.contentrheum.com/faq-video-detail-page/definition-of-remission-in-rheumatoid-arthritis-likelihood-with-advanced-therapies 2025-01-15T06:42:28+00:00 0.80 https://www.contentrheum.com/faq-video-detail-page/what-is-the-oral-surveillance-study-and-how-can-it-be-applied-to-clinical-practice 2025-01-15T06:42:28+00:00 0.80 https://www.contentrheum.com/medical-review-video-detail-page/what-is-the-safety-profile-of-upadacitinib-across-indications 2025-01-15T06:42:28+00:00 0.80 https://www.contentrheum.com/faq-video-detail-page/variability-in-jak-inhibition-specificity-its-clinical-implications 2025-01-15T06:42:28+00:00 0.80 https://www.contentrheum.com/medical-review-video-detail-page/how-is-upadacitinib-dosed-across-rheumatologic-indications 2025-01-15T06:42:28+00:00 0.80 https://www.contentrheum.com/medical-review-video-detail-page/describe-the-mechanism-of-action-of-upadacitinib 2025-01-15T06:42:28+00:00 0.80 https://www.contentrheum.com/faq-video-detail-page/provide-immunologic-rationale-for-jak-directed-therapy-in-rheumatic-disease 2025-01-15T06:42:28+00:00 0.80 https://www.contentrheum.com/faq-video-detail-page/describe-jak-stat-signaling-in-inflammation 2025-01-15T06:42:28+00:00 0.80 https://www.contentrheum.com/disease-detail/jak 2025-01-15T06:42:28+00:00 0.80 https://www.contentrheum.com/faq-video-detail-page/what-is-the-difference-between-biosimilars-and-generics 2025-01-15T06:42:28+00:00 0.80 https://www.contentrheum.com/faq-video-detail-page/what-does-it-mean-for-a-biosimilar-to-be-interchangeable-and-why-is-that-important 2025-01-15T06:42:28+00:00 0.80 https://www.contentrheum.com/disease-detail/biosimilars 2025-01-15T06:42:28+00:00 0.80 https://www.contentrheum.com/disease-detail/general 2025-01-15T06:42:28+00:00 0.64 https://www.contentrheum.com/disease-detail/csdmards 2025-01-15T06:42:28+00:00 0.64 https://www.contentrheum.com/rheumatology-advanced-practice-providers 2025-02-06T06:38:35+00:00 0.64 https://www.contentrheum.com/rhapp-annual-conference-2025 2025-02-06T06:38:35+00:00 0.64 https://www.contentrheum.com/rheumatology-education-for-apps 2025-02-06T06:38:35+00:00 0.64 https://www.contentrheum.com/continuing-education-for-nurse-practitioners-in-rheumatology 2025-02-06T06:38:35+00:00 0.64 https://www.contentrheum.com/continuing-education-for-physician-assistants-in-rheumatology 2025-02-06T06:38:35+00:00 0.64 https://www.contentrheum.com/rheumatic-disease-management-for-apps 2025-02-06T06:38:35+00:00 0.64 https://www.contentrheum.com/chronic-autoimmune-disease-education-for-apps 2025-02-06T06:38:35+00:00 0.64 https://www.contentrheum.com/rhapp-membership-benefits 2025-02-06T06:38:35+00:00 0.64 https://www.contentrheum.com/rhapp-regional-meetings-2024 2025-02-06T06:38:35+00:00 0.64 https://www.contentrheum.com/rhapp-online-education-resources 2025-02-06T06:38:35+00:00 0.64 https://www.contentrheum.com/networking-for-rheumatology-apps 2025-02-06T06:38:35+00:00 0.64 https://www.contentrheum.com/professional-development-in-rheumatology-for-apps 2025-02-06T06:38:35+00:00 0.64 https://www.contentrheum.com/rhapp-conference-registration 2025-02-06T06:38:35+00:00 0.64 https://www.contentrheum.com/rheumatology-podcasts-for-apps 2025-02-06T06:38:35+00:00 0.64 https://www.contentrheum.com/ai-tools-in-rheumatology-practice 2025-02-06T06:38:35+00:00 0.64